Immunology

Antibody findings spark ideas for pan-coronavirus vaccine

Three epidemic or pandemic coronaviruses—SARS-CoV, MERS-CoV, & SARS-CoV-2—have spilled over from animals to cause deadly illness in humans in the past 20 years. Virus researchers are determined to discover a means to ...

Diseases, Conditions, Syndromes

Making the case for intranasal COVID-19 vaccines

A microbiologist and an immunologist from the University of Alabama at Birmingham have published a Perspective piece in the journal Science outlining the possible benefits of developing COVID-19 vaccines delivered in an intranasal ...

Medical research

Stanford developing single-dose nanoparticle vaccine for COVID-19

Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, ...

Diseases, Conditions, Syndromes

What should a successful SARS-CoV-2 vaccine do?

A lot has been written recently about the merits of different potential vaccines for SARS-CoV-2. "Merit" is generally assumed to mean that the vaccine will make us immune. But what, exactly, is immunity, and how would we ...

page 1 from 616